Understanding the STONE Scoring System

The STONE (Size, Tract length, Obstruction, Number of calyces, Essence/density) scoring system emerged from research by Okhunov et al. in 2013 as a standardised method for predicting PCNL success. Each component reflects a distinct anatomical challenge that complicates stone removal:

  • Stone size—measured in square millimetres as length multiplied by width on axial CT imaging. Larger calculi occupy more space and require more fragmentation time.
  • Tract length—the distance in millimetres from the stone centre to the skin, measured perpendicular to the collecting system. Longer tracts increase operative time and bleeding risk.
  • Obstruction severity—presence and grade of hydronephrosis, which indicates whether the stone has already obstructed urine flow.
  • Number of calyces involved—stones confined to a single calyx are simpler to access than those branching into multiple collecting system compartments (staghorn stones).
  • Stone density—measured in Hounsfield units (HU). Harder stones (higher density) require more intensive fragmentation and prolong procedure duration.

STONE Score Calculation

The STONE score combines five CT-derived variables into a single predictive value. Each variable contributes points based on severity thresholds. The final score correlates with the probability of achieving a stone-free outcome (complete calculus removal on post-operative imaging) after a single PCNL procedure.

STONE Score = Stone Size + Tract Length + Obstruction + Calyces + Stone Density

  • Stone Size — Cross-sectional area in mm² (length × width on CT). Ranges from 0 to 3 points depending on threshold.
  • Tract Length — Distance from stone to skin in mm, measured at 0°, 45°, and 90° angles. Scored 0–2 points.
  • Obstruction — Presence and grade of hydronephrosis. Assigned 0–2 points; absent=0, mild-moderate=1, severe=2.
  • Number of Calyces — Count of major or minor calyces containing calculi. Single calyx=0 points; multiple or staghorn=1–2 points.
  • Stone Density — Measured in Hounsfield units (HU). Range 0–3 points; higher density (>1000 HU) scores higher.

Performing Percutaneous Nephrolithotomy

PCNL is an invasive surgical procedure best reserved for large, complex stones or failed attempts at less invasive techniques. The procedure unfolds under general anesthesia in a sterile operating room:

  1. Access creation—the surgeon creates a small incision (typically 1–2 cm) on the patient's back overlying the kidney, then advances a hollow sheath into the renal calyx under fluoroscopic or ultrasound guidance.
  2. Stone visualisation—a telescope (nephroscope) inserted through the sheath allows direct visualisation of the calculus and collecting system anatomy.
  3. Stone fragmentation—various energy sources (laser, ultrasound, pneumatic hammer) pulverise the stone into smaller fragments that can be retrieved or flushed out.
  4. Fragment removal—suction irrigation removes stone pieces and debris. The surgeon inspects the calyx to confirm clearance.
  5. Stent placement—a ureteric stent is often left in situ for 1–2 weeks to ensure urine drainage and aid healing.

Bleeding, infection, and ureteric injury are recognised risks, though serious complications occur in fewer than 10% of procedures when performed by experienced surgeons.

Key Considerations for STONE Scoring

Accurate CT measurement and clinical interpretation are essential for reliable prognostication.

  1. CT measurement technique matters — Stone size and tract length must be measured on thin-slice (≤2 mm) arterial or portal-venous phase CT. Coronal and axial views help distinguish true length and width. Oblique reformats at 0°, 45°, and 90° angles are needed for tract length to capture the longest, most challenging access route. Poor imaging quality or incorrect plane selection can underestimate difficulty and overestimate success probability.
  2. Hydronephrosis grading varies — Obstruction severity (mild, moderate, severe) is subjective and depends on pelvicalyceal dilation degree and renal parenchymal thickness. Some radiologists grade conservatively, others liberally. Direct review of the CT by the operating surgeon reduces interpretation disagreement and ensures the STONE score reflects the actual anatomical challenge.
  3. Stone density affects fragmentation energy — Calculi exceeding 1200 Hounsfield units (such as calcium oxalate monohydrate) are significantly harder than lower-density stones (uric acid, brushite). Denser stones require prolonged laser exposure or multiple energy modalities, extending operative time and increasing heat-related injury risk. Density thresholds in the STONE system account for this but cannot predict all fragmentation difficulties.
  4. Staghorn stones carry higher morbidity — Calculi that occupy multiple calyces or the entire pelvicalyceal system (staghorn morphology) often require staged procedures or multiple tracts to achieve stone-free status. A single PCNL may clear only 70–80% of a large staghorn stone. Plan for possible second-stage intervention when scoring indicates complex anatomy.

Beyond STONE: Preventing Recurrence

Although the STONE score predicts single-procedure success, many patients face recurrent stone formation within 5–10 years if underlying risk factors persist. Post-operative stone prevention involves metabolic evaluation and lifestyle modification:

  • Hydration status—urine concentration drives stone crystallisation. Maintaining urine output exceeding 2–2.5 litres per day significantly reduces recurrence risk.
  • Dietary habits—excessive animal protein, high-dose sodium, and high-dose vitamin D all elevate urinary calcium and uric acid. Moderating these intake levels addresses root causes.
  • Anatomical factors—benign prostatic hyperplasia or urinary tract obstruction predisposes to stone formation. Treating underlying conditions reduces recurrence.
  • Genetic predisposition—family history of nephrolithiasis and rare monogenic diseases (e.g., primary hyperoxaluria) require specialist metabolic management and sometimes prophylactic medical therapy.
  • Infections—recurrent urinary tract infections promote struvite and carbonate apatite stone formation. Prompt UTI treatment and urologic follow-up are essential.

Frequently Asked Questions

How is kidney stone size measured from a CT scan?

Stone size for the STONE system is calculated as the product of the longest and widest dimensions visible on axial CT, expressed in square millimetres. Using CT measurement tools, identify the calculus on axial images and mark the maximum length and width perpendicular to each other. Multiply these two values (e.g., a 10 mm × 8 mm stone = 80 mm²). Multi-planar reformats ensure you capture true length and width rather than oblique measurements. Accurate sizing is crucial because larger stones score higher points and predict lower success rates.

What happens if I inherit a genetic predisposition to kidney stones?

Genetic factors significantly increase susceptibility, but inheritance is not deterministic. Rare autosomal recessive conditions like primary hyperoxaluria type 1 (PH1) cause early-onset, aggressive stone disease. More common is a polygenic predisposition associated with calcium metabolism and urinary pH regulation. Even with a strong family history, adherence to preventive strategies—high fluid intake, moderate protein and sodium, adequate but not excessive vitamin D—can delay or prevent stone formation for many years. Genetic counselling and urine metabolic screening help identify high-risk relatives early.

Do kidney stones permanently damage kidney function?

Most kidney stones produce only minor, reversible effects on glomerular filtration rate (GFR). A single obstructed kidney typically recovers normal or near-normal function within weeks to months after stone removal. Chronic recurrent obstruction, however, can gradually erode renal parenchyma and cause chronic kidney disease over decades. Early stone detection and aggressive preventive management are key: treating even small, asymptomatic stones detected incidentally on imaging can prevent irreversible damage. Patients with recurrent stones warrant annual renal function monitoring and metabolic evaluation.

Does excess vitamin D supplementation increase stone risk?

Yes. Vitamin D hypervitaminosis—typically from supplementing well above recommended daily intake (>4,000 IU/day long-term)—elevates serum calcium and urinary calcium excretion, promoting calcification. While vitamin D is essential for bone and immune health, megadosing without medical indication substantially raises nephrolithiasis risk in susceptible individuals. Serum vitamin D levels should be maintained in the replete range (30–50 ng/mL) rather than maximised. Patients with a personal or family history of kidney stones should avoid high-dose supplements and seek individualised dietary advice rather than self-prescribing.

What does tract length tell us about PCNL difficulty?

Tract length—measured from the stone to the skin surface—reflects the depth of kidney penetration required during access creation. Shorter tracts (<10 cm) are straightforward; intermediate tracts (10–15 cm) are standard; longer tracts (>15 cm) demand careful needle placement and increase blood loss risk because of prolonged parenchymal trauma. Tract length also influences operative time and stone fragmentation duration. The STONE system weights longer tracts higher because they correlate with lower stone-free rates and higher morbidity. Surgeons may select alternative approaches (e.g., mini-PCNL, flexible ureteroscopy) when tract length exceeds 20 cm.

Can staghorn stones be removed in a single PCNL procedure?

Small to medium staghorn stones (occupying 2–3 calyces, <500 mm²) may be cleared in one session by experienced surgeons using percutaneous access combined with flexible instruments. Large staghorn configurations, however, are typically managed with staged procedures 1–2 weeks apart, allowing tissue swelling to resolve and promoting safer second-stage access. The STONE score predicts single-procedure success; staging rates climb significantly when multiple major calyces or the entire pelvicalyceal system is involved. Your surgeon will discuss staging likelihood based on stone anatomy, your health status, and institutional expertise.

More health calculators (see all)